Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1984 Apr;73(4):1201–1214. doi: 10.1172/JCI111306

The biology of tumor growth in the non-Hodgkin's lymphomas. A dual parameter flow cytometry study of 220 cases.

S E Shackney, A M Levine, R I Fisher, P Nichols, E Jaffe, W H Schuette, R Simon, C A Smith, S J Occhipinti, J W Parker, et al.
PMCID: PMC425134  PMID: 6608531

Abstract

Dual parameter flow cytometry studies (cell DNA content and electronic cell volume) were performed in 220 cases of non-Hodgkin's lymphoma. All cases were characterized as B or T cell malignancies, based on immunologic surface marker characteristics. Aneuploidy by flow cytometry was more common among the B cell lymphomas than among the T cell lymphomas, and was most common among the large B cell lymphomas and B cell lymphomas of intermediate size. Ploidy index distributions showed a prominent hyperdiploid peak, as well as tumor cell populations with near-tetraploid DNA contents. In serial studies, a decrease in ploidy index was observed in association with clinical and histologic transformation in one case. The highest S fractions were observed among the large and intermediate B cell lymphomas and among the aggressive T cell lymphomas. In clinical samples consisting of mixtures of diploid and aneuploid populations, the data on the aneuploid components could often be separated from other components of the mixture in multiparameter studies on the basis of the larger electronic cell volumes of the aneuploid cells. In each case, the aneuploid large cell component almost invariably had a higher S fraction than the residual component(s) of the mixture. Overall, the data are consistent with a model of clonal selection and clonal evolution in the lymphomas in which early cytogenetic abnormalities that involve little or no change in total cell DNA content are followed by cell tetraploidization that is associated with cytogenetic instability and chromosome loss over the course of time.

Full text

PDF
1201

Images in this article

1210Image
on p.1210
1212Image
on p.1212

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Acker B., Hoppe R. T., Colby T. V., Cox R. S., Kaplan H. S., Rosenberg S. A. Histologic conversion in the non-Hodgkin's lymphomas. J Clin Oncol. 1983 Jan;1(1):11–16. doi: 10.1200/JCO.1983.1.1.11. [DOI] [PubMed] [Google Scholar]
  2. Anderson T., Bender R. A., Fisher R. I., DeVita V. T., Chabner B. A., Berard C. W., Norton L., Young R. C. Combination chemotherapy in non-Hodgkin's lymphoma: results of long-term followup. Cancer Treat Rep. 1977 Sep;61(6):1057–1066. [PubMed] [Google Scholar]
  3. Barlogie B., Göhde W., Johnston D. A., Smallwood L., Schumann J., Drewinko B., Freireich E. J. Determination of ploidy and proliferative characteristics of human solid tumors by pulse cytophotometry. Cancer Res. 1978 Oct;38(10):3333–3339. [PubMed] [Google Scholar]
  4. Barlogie B., Hittelman W., Spitzer G., Trujilo J. M., Hart J. S., Smallwood L., Drewinko B. Correlation of DNA distribution abnormalities with cytogenetic findings in human adult leukemia and lymphoma. Cancer Res. 1977 Dec;37(12):4400–4407. [PubMed] [Google Scholar]
  5. Barlogie B., Latreille J., Freireich E. J., Fu C. T., Mellard D., Meistrich M., Andreeff M. Characterization of hematologic malignancies by flow cytometry. Blood Cells. 1980;6(4):719–744. [PubMed] [Google Scholar]
  6. Braylan R. C., Fowlkes B. J., Jaffe E. S., Sanders S. K., Berard C. W., Herman C. J. Cell volumes and DNA distributions of normal and neoplastic human lymphoid cells. Cancer. 1978 Jan;41(1):201–209. doi: 10.1002/1097-0142(197801)41:1<201::aid-cncr2820410129>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  7. Bunn P. A., Jr, Krasnow S., Makuch R. W., Schlam M. L., Schechter G. P. Flow cytometric analysis of DNA content of bone marrow cells in patients with plasma cell myeloma: clinical implications. Blood. 1982 Mar;59(3):528–535. [PubMed] [Google Scholar]
  8. Bunn P. A., Jr, Whang-Peng J., Carney D. N., Schlam M. L., Knutsen T., Gazdar A. F. DNA content analysis by flow cytometry and cytogenetic analysis in mycosis fungoides and Sézary syndrome. J Clin Invest. 1980 Jun;65(6):1440–1448. doi: 10.1172/JCI109808. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cadman E., Farber L., Berd D., Bertino J. Combination therapy for diffuse histiocytic lymphoma that includes antimetabolites. Cancer Treat Rep. 1977 Sep;61(6):1109–1116. [PubMed] [Google Scholar]
  10. Clifford P., Gripenberg U., Klein E., Fenyo E. M., Manolov G. Treatment of Burkitt's lymphoma. Lancet. 1968 Aug 31;2(7566):517–518. doi: 10.1016/s0140-6736(68)90681-8. [DOI] [PubMed] [Google Scholar]
  11. Cossman J., Jaffe E. S. Distribution of complement receptor subtypes in non-Hodgkin's lymphomas of B-cell origin. Blood. 1981 Jul;58(1):20–26. [PubMed] [Google Scholar]
  12. Costa A., Mazzini G., Del Bino G., Silvestrini R. DNA content and kinetic characteristics of non-Hodgkin's lymphoma: determined by flow cytometry and autoradiography. Cytometry. 1981 Nov;2(3):185–188. doi: 10.1002/cyto.990020310. [DOI] [PubMed] [Google Scholar]
  13. Coutinho V., Bottura C., Falcao R. P. Cytogenetic studies in malignant lymphomas: a study of 8 cases. Br J Cancer. 1971 Dec;25(4):789–801. doi: 10.1038/bjc.1971.93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Cullen M. H., Lister T. A., Brearley R. I., Shand W. S., Stansfeld A. G. Histological transformation of non-Hodgkin's lymphoma: a prospective study. Cancer. 1979 Aug;44(2):645–651. doi: 10.1002/1097-0142(197908)44:2<645::aid-cncr2820440234>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  15. Cunningham R. E., Skramstad K. S., Newburger A. E., Shackney S. E. Artifacts associated with mithramycin fluorescence in the clinical detection and quantitation of aneuploidy by flow cytometry. J Histochem Cytochem. 1982 Apr;30(4):317–322. doi: 10.1177/30.4.6460801. [DOI] [PubMed] [Google Scholar]
  16. DeVita V. T., Jr, Canellos G. P., Chabner B., Schein P., Hubbard S. P., Young R. C. Advanced diffuse histiocytic lymphoma, a potentially curable disease. Lancet. 1975 Feb 1;1(7901):248–250. doi: 10.1016/s0140-6736(75)91142-3. [DOI] [PubMed] [Google Scholar]
  17. Diamond L. W., Braylan R. C. Flow analysis of DNA content and cell size in non-Hodgkin's lymphoma. Cancer Res. 1980 Mar;40(3):703–712. [PubMed] [Google Scholar]
  18. Diamond L. W., Nathwani B. N., Rappaport H. Flow cytometry in the diagnosis and classification of malignant lymphoma and leukemia. Cancer. 1982 Sep 15;50(6):1122–1135. doi: 10.1002/1097-0142(19820915)50:6<1122::aid-cncr2820500616>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  19. Finan J., Daniele R., Rowlands D., Jr, Nowell P. Cytogenetics of chronic T cell leukemia, including two patients with a 14q+ translocation. Virchows Arch B Cell Pathol. 1978 Nov 17;29(1-2):121–127. doi: 10.1007/BF02899345. [DOI] [PubMed] [Google Scholar]
  20. Fisher R. I., DeVita V. T., Jr, Hubbard S. M., Longo D. L., Wesley R., Chabner B. A., Young R. C. Diffuse aggressive lymphomas: increased survival after alternating flexible sequences of proMACE and MOPP chemotherapy. Ann Intern Med. 1983 Mar;98(3):304–309. doi: 10.7326/0003-4819-98-3-304. [DOI] [PubMed] [Google Scholar]
  21. Fisher R. I., DeVita V. T., Jr, Johnson B. L., Simon R., Young R. C. Prognostic factors for advanced diffuse histiocytic lymphoma following treatment with combination chemotherapy. Am J Med. 1977 Aug;63(2):177–182. doi: 10.1016/0002-9343(77)90230-3. [DOI] [PubMed] [Google Scholar]
  22. Fleischman E. W., Prigogina E. L. Karyotype peculiarities of malignant lymphomas. Hum Genet. 1977 Mar 14;35(3):269–279. doi: 10.1007/BF00446620. [DOI] [PubMed] [Google Scholar]
  23. Fukuhara S., Rowley J. D. Chromosome 14 translocations in non-Burkitt lymphomas. Int J Cancer. 1978 Jul 15;22(1):14–21. doi: 10.1002/ijc.2910220105. [DOI] [PubMed] [Google Scholar]
  24. Fukuhara S., Rowley J. D., Variakojis D., Golomb H. M. Chromosome abnormalities in poorly differentiated lymphocytic lymphoma. Cancer Res. 1979 Aug;39(8):3119–3128. [PubMed] [Google Scholar]
  25. Fukuhara S., Rowley J. D., Variakojis D., Sweet D. L., Jr Banding studies on chromosomes in diffuse "histiocytic" lymphomas: correlation of 14q+ marker chromosome with cytology. Blood. 1978 Nov;52(5):989–1002. [PubMed] [Google Scholar]
  26. Isaacs J. T., Wake N., Coffey D. S., Sandberg A. A. Genetic instability coupled to clonal selection as a mechanism for tumor progression in the Dunning R-3327 rat prostatic adenocarcinoma system. Cancer Res. 1982 Jun;42(6):2353–2371. [PubMed] [Google Scholar]
  27. Jaffe E. S., Shevach E. M., Frank M. M., Berard C. W., Green I. Nodular lymphoma--evidence for origin from follicular B lymphocytes. N Engl J Med. 1974 Apr 11;290(15):813–819. doi: 10.1056/NEJM197404112901501. [DOI] [PubMed] [Google Scholar]
  28. Jaffe E. S., Strauchen J. A., Berard C. W. Predictability of immunologic phenotype by morphologic criteria in diffuse aggressive non-Hodgkin's lymphomas. Am J Clin Pathol. 1982 Jan;77(1):46–49. doi: 10.1093/ajcp/77.1.46. [DOI] [PubMed] [Google Scholar]
  29. Jones S. E., Fuks Z., Bull M., Kadin M. E., Dorfman R. F., Kaplan H. S., Rosenberg S. A., Kim H. Non-Hodgkin's lymphomas. IV. Clinicopathologic correlation in 405 cases. Cancer. 1973 Apr;31(4):806–823. doi: 10.1002/1097-0142(197304)31:4<806::aid-cncr2820310408>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  30. Kaneko Y., Abe R., Sampi K., Sakurai M. An analysis of chromosome findings in non-Hodgkin's lymphomas. Cancer Genet Cytogenet. 1982 Feb;5(2):107–121. doi: 10.1016/0165-4608(82)90002-4. [DOI] [PubMed] [Google Scholar]
  31. Kruth H. S., Braylan R. C., Benson N. A., Nourse V. A. Simultaneous analysis of DNA and cell surface immunoglobulin in human B-cell lymphomas by flow cytometry. Cancer Res. 1981 Dec;41(12 Pt 1):4895–4899. [PubMed] [Google Scholar]
  32. Lukes R. J., Collins R. D. Immunologic characterization of human malignant lymphomas. Cancer. 1974 Oct;34(4 Suppl):suppl–suppl:1503. doi: 10.1002/1097-0142(197410)34:8+<1488::aid-cncr2820340822>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  33. Lukes R. J., Parker J. W., Taylor C. R., Tindle B. H., Cramer A. D., Lincoln T. L. Immunologic approach to non-Hodgkin lymphomas and related leukemias. Analysis of the results of multiparameter studies of 425 cases. Semin Hematol. 1978 Oct;15(4):322–351. [PubMed] [Google Scholar]
  34. Lukes R. J., Taylor C. R., Parker J. W., Lincoln T. L., Pattengale P. K., Tindle B. H. A morphologic and immunologic surface marker study of 299 cases of non-Hodgkin lymphomas and related leukemias. Am J Pathol. 1978 Feb;90(2):461–486. [PMC free article] [PubMed] [Google Scholar]
  35. Mark J., Ekedahl C., Hagman A. Origin of the translocated segment of the 14q+ marker in non-Burkitt lymphomas. Hum Genet. 1977 May 10;36(3):277–282. doi: 10.1007/BF00446277. [DOI] [PubMed] [Google Scholar]
  36. Meijer C. J., van der Loo E. M., van Vloten W. A., van der Velde E. A., Scheffer E., Cornelisse C. J. Early diagnosis of mycosis fungoides and Sézary's syndrome by morphometric analysis of lymphoid cells in the skin. Cancer. 1980 Jun 1;45(11):2864–2871. doi: 10.1002/1097-0142(19800601)45:11<2864::aid-cncr2820451124>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  37. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project. Cancer. 1982 May 15;49(10):2112–2135. doi: 10.1002/1097-0142(19820515)49:10<2112::aid-cncr2820491024>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  38. Nowell P. C. The clonal evolution of tumor cell populations. Science. 1976 Oct 1;194(4260):23–28. doi: 10.1126/science.959840. [DOI] [PubMed] [Google Scholar]
  39. Portlock C. S., Rosenberg S. A. No initial therapy for stage III and IV non-Hodgkin's lymphomas of favorable histologic types. Ann Intern Med. 1979 Jan;90(1):10–13. doi: 10.7326/0003-4819-90-1-10. [DOI] [PubMed] [Google Scholar]
  40. Reeves B. R. Cytogenetics of malignant lymphomas. Studies utilising a Giemsa-banding technique. Humangenetik. 1973 Dec 10;20(3):231–250. doi: 10.1007/BF00385735. [DOI] [PubMed] [Google Scholar]
  41. Risdall R., Hoppe R. T., Warnke R. Non-Hodgkin's lymphoma: a study of the evolution of the disease based upon 92 autopsied cases. Cancer. 1979 Aug;44(2):529–542. doi: 10.1002/1097-0142(197908)44:2<529::aid-cncr2820440222>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  42. Ritch P. S., Shackney S. E., Schuette W. H., Talbot T. L., Smith C. A. A practical graphical method for estimating the fraction of cells in S in DNA histograms from clinical tumor samples containing aneuploid cell populations. Cytometry. 1983 Jul;4(1):66–74. doi: 10.1002/cyto.990040110. [DOI] [PubMed] [Google Scholar]
  43. Rowley J. D., Fukuhara S. Chromosome studies in non-Hodgkin's lymphomas. Semin Oncol. 1980 Sep;7(3):255–266. [PubMed] [Google Scholar]
  44. Salzman G. C., Hiebert R. D., Crowell J. M. Data acquisition and display for a high-speed cell sorter. Comput Biomed Res. 1978 Feb;11(1):77–88. doi: 10.1016/0010-4809(78)90048-4. [DOI] [PubMed] [Google Scholar]
  45. Sandberg A. A. Chromosome changes in the lymphomas. Hum Pathol. 1981 Jun;12(6):531–540. doi: 10.1016/s0046-8177(81)80067-6. [DOI] [PubMed] [Google Scholar]
  46. Schein P. S., Chabner B. A., Canellos G. P., Young R. C., Berard C., DeVita V. T. Potential for prolonged disease-free survival following combination chemotherapy of non-Hodgkin's lymphoma. Blood. 1974 Feb;43(2):181–189. [PubMed] [Google Scholar]
  47. Schuette W. H., Shackney S. E., MacCollum M. A., Smith C. A. High resolution method for the analysis of DNA histograms that is suitable for the detection of multiple aneuploid G1 peaks in clinical samples. Cytometry. 1983 Mar;3(5):376–386. doi: 10.1002/cyto.990030512. [DOI] [PubMed] [Google Scholar]
  48. Shackney S. E., Erickson B. W., Skramstad K. S. The T-lymphocyte as a diploid reference standard for flow cytometry. Cancer Res. 1979 Nov;39(11):4418–4422. [PubMed] [Google Scholar]
  49. Shackney S. E., Skramstad K. S., Cunningham R. E., Dugas D. J., Lincoln T. L., Lukes R. J. Dual parameter flow cytometry studies in human lymphomas. J Clin Invest. 1980 Dec;66(6):1281–1294. doi: 10.1172/JCI109980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Shackney S. E., Skramstad K. A dynamic interpretation of multiparameter studies in the lymphomas. Am J Clin Pathol. 1979 Oct;72(4 Suppl):756–764. [PubMed] [Google Scholar]
  51. Yunis J. J., Oken M. M., Kaplan M. E., Ensrud K. M., Howe R. R., Theologides A. Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin's lymphoma. N Engl J Med. 1982 Nov 11;307(20):1231–1236. doi: 10.1056/NEJM198211113072002. [DOI] [PubMed] [Google Scholar]
  52. van Vloten W. A., Pet E. A., Geraedts J. P. Chromosome studies in mycosis fungoides. Br J Dermatol. 1980 May;102(5):507–513. doi: 10.1111/j.1365-2133.1980.tb07647.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES